Poly(ADP-ribose) polymerase (PARP) plays an essential role in single-strand DNA repair, and PARP inhibitors have shown anticancer activity against HER2-negative breast cancer cells associated with BRCA1/BRCA2 mutations [126]. This evidence concerns the gene BRCA1 and breast cancer.